Juvenile oncology--a missing subspecialty. The experience of a reference cancer centre

Απλή σελίδα τεκμηρίου
dc.contributor.authorPentheroudakis, G.en
dc.contributor.authorMauri, D.en
dc.contributor.authorKostadima, L.en
dc.contributor.authorGolfinopoulos, V.en
dc.contributor.authorAlexiou, G.en
dc.contributor.authorKarakatsanis, A.en
dc.contributor.authorPavlidis, N.en
dc.date.accessioned2015-11-24T19:08:35Z
dc.date.available2015-11-24T19:08:35Z
dc.identifier.issn1699-048X-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/20548
dc.rightsDefault Licence-
dc.subjectAcademic Medical Centers/statistics & numerical dataen
dc.subjectAdolescenten
dc.subjectAdulten
dc.subjectAntineoplastic Agents/adverse effectsen
dc.subjectCancer Care Facilities/*statistics & numerical dataen
dc.subjectDiagnosis-Related Groupsen
dc.subjectFemaleen
dc.subjectGreece/epidemiologyen
dc.subjectHospitals, University/statistics & numerical dataen
dc.subjectHumansen
dc.subjectIncidenceen
dc.subjectInterdisciplinary Communicationen
dc.subjectMaleen
dc.subject*Medical Oncologyen
dc.subjectNeoplasms/*epidemiology/psychology/therapyen
dc.subjectPatient Care Teamen
dc.subject*Pediatricsen
dc.subjectPostoperative Complications/epidemiologyen
dc.subjectQuality of Lifeen
dc.subjectRadiotherapy/adverse effectsen
dc.subjectReferral and Consultationen
dc.subjectRetrospective Studiesen
dc.subjectSocial Supporten
dc.subjectSurvival Analysisen
dc.subjectSurvival Rateen
dc.titleJuvenile oncology--a missing subspecialty. The experience of a reference cancer centreen
heal.abstractINTRODUCTION: Despite unique tumor epidemiology and a higher cancer incidence compared to pediatric patients, adolescents and young adults have not been receiving specialized, multidisciplinary, centralized care. In an effort to emphasize this need, we present outcome and toxicity data from a reference centre. METHODS: Cohort of 150 patients aged 15-30 treated for malignant tumors of lymphoid and solid organs from 1986 to 2002. RESULTS: Patients aged 15-19 commonly had lymphomas, germ cell tumors and pediatric sarcomas, whereas those aged 20-30 experienced germ cell tumors, lymphomas, melanomas and epithelial tumors more often. Overall 5- and 10-year survival was 80%, whereas 5-year and 10-year time to treatment failure was 68% and 43.5% respectively. 24% of patients experienced persistent, late treatment-related toxicities that interfered with their normal lifestyle. CONCLUSION: Despite the need for specialized care, psychosocial support and enrollment in clinical trials, youngsters have not been recognized as a patient group with distinct needs. Development of "Juvenile" oncology is required.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/16790398-
heal.identifier.secondaryhttp://www.springerlink.com/content/k4r25882027520g4/fulltext.pdf-
heal.journalNameClin Transl Oncolen
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate2006-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή:
Κατεβάστε

Συλλογές

Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ